SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-047759
Filing Date
2024-04-16
Accepted
2024-04-16 16:00:08
Documents
4
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm242993-2_pre14a.htm PRE 14A 849643
2 GRAPHIC lg_hookipapharma-4c.jpg GRAPHIC 13094
3 GRAPHIC px_24hookpxy01pg01-bw.jpg GRAPHIC 252245
4 GRAPHIC px_24hookpxy01pg02-bw.jpg GRAPHIC 183016
  Complete submission text file 0001104659-24-047759.txt   1407830
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38869 | Film No.: 24847747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)